Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-47.71%
↑ 41% above average
Average (9y)
-81.48%
Historical baseline
Range
High:136.71%
Low:-678.78%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -47.71% |
| 2023 | -51.53% |
| 2022 | -678.78% |
| 2021 | 136.71% |
| 2020 | -24.13% |
| 2019 | 24.17% |
| 2018 | -22.47% |
| 2017 | -41.56% |
| 2016 | -113.36% |
| 2015 | 3.84% |